chr4-2831582-C-T
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong
The ENST00000503393.8(SH3BP2):c.1253C>T(p.Pro418Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000696 in 1,435,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P418R) has been classified as Pathogenic.
Frequency
Consequence
ENST00000503393.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3BP2 | NM_001122681.2 | c.1253C>T | p.Pro418Leu | missense_variant | 9/13 | ENST00000503393.8 | NP_001116153.1 | |
SH3BP2 | NM_001145856.2 | c.1424C>T | p.Pro475Leu | missense_variant | 9/13 | NP_001139328.1 | ||
SH3BP2 | NM_001145855.2 | c.1337C>T | p.Pro446Leu | missense_variant | 9/13 | NP_001139327.1 | ||
SH3BP2 | NM_003023.4 | c.1253C>T | p.Pro418Leu | missense_variant | 9/13 | NP_003014.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3BP2 | ENST00000503393.8 | c.1253C>T | p.Pro418Leu | missense_variant | 9/13 | 1 | NM_001122681.2 | ENSP00000422168 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.96e-7 AC: 1AN: 1435998Hom.: 0 Cov.: 32 AF XY: 0.00000140 AC XY: 1AN XY: 711922
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Fibrous dysplasia of jaw Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Jan 28, 2022 | PS4, PM1, PM5, PM2, PP3, PP5 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2001 | - - |
Pathogenic, no assertion criteria provided | research | Clinical Genetics Laboratory, Federal University of Health Sciences of Porto Alegre | Mar 18, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 16, 2021 | This variant disrupts the p.Pro418 amino acid residue in SH3BP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17321449, 18596838, 28644570, 23298620, 11381256). This suggests that this residue is clinically-significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been reported to affect SH3BP2 protein function (PMID: 22153077). This variant has been observed in individuals and families affected with cherubism (PMID: 11381256, 27272835, 23298620). ClinVar contains an entry for this variant (Variation ID: 7547). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 418 of the SH3BP2 protein (p.Pro418Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at